UPMC HSCT Program
Locations
Transplant Summary
Overview
The Transplantation Program at UPMC Cancer Center offers comprehensive Adult SCT services, including autologous/syngeneic peripheral blood transplants, allogeneic peripheral blood, and bone marrow transplants from HLA-matched or partially HLA-mismatched related or unrelated donors. In addition, CAR-T therapy is offered as a treatment option for some types of lymphoma and leukemia.This center has been performing allogeneic transplants since 1985 and has been an NMDP transplant center since July 1987.
Attending physicians
Adult - Mounzer Agha, Kathleen Dorritie, Rafic Farah, Joseph Franz, Natalie Galanina, Jing-Zhou Hou, Annie Im, Sawa Ito, Anastasios Raptis, James Rossetti, Alison Sehgal, Warren ShlomchikTransplants performed
Marrow/PBSC and single cordCord blood transplants
Adult onlyPatient survival information for this center
This center's actual 1-year survival results are below the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 132 patients.The actual 1-year survival of these patients is 63.8%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 63.9% and 78.5%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.
The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.
Total adult transplants
248
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow3PBSC39Cord blood0Total42Unrelated donorMarrow0PBSC50Cord blood1Total51Total allogeneicMarrow3PBSC89Cord blood1Total93AutologousMarrowBoth marrow & PBSC 155PBSC—Cord blood—Total155Total combinedMarrowBoth marrow & PBSC 247PBSC—Cord blood1Total248All Diseases
Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)
0-18 19-44 45-64 65+ Total Related 0-18019-44945-641865+15Total42Unrelated 0-18019-441145-641965+21Total51Autologous 0-18019-443345-647165+51Total155Total 0-18019-445345-6410865+87Total248Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants can be found:
- U.S. Transplant Data by Center (Opens in a new tab) report at blood cell.transplant.hrsa.gov
- List of diseases
Transplant center resources
NMDP patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
- Inside the United States: 1 (888) 999-6743
- Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)
Email: patientinfo@nmdp.org
More resources
- Choosing a transplant center
- Preparing for transplant
- Learn about transplant outcomes and treatment decisions (Opens in a new tab)
- Support and resources (including non-English materials)
- U.S. Transplant Data by Center (Opens in a new tab) at blood cell.transplant.hrsa.gov
UPMC Hillman Cancer Center
5150 Centre Ave Pittsburgh, PA 15232 Phone:412-864-6627 Overview
The Long Term follow-up and Chronic GVHD Clinic at UPMC Hillman Cancer Center provides long term care for stem cell transplant survivors, and works to coordinate care in conjunction with the transplant physician, specialists, and primary care physician. Long term care plans that follow guidelines for surveillance, preventive care, and ancillary therapies are developed and provided to the patient, caregivers, and medical team.
Staff
Program Director:Dr. Annie Im, MDProgram Coordinator:Cheryl Thompkins, CRNPMedical Specialties in Program
Allergy/immunology, cardiology, complementary and alternative medicine, dentistry, dermatology, endocrinology, gastroenterology, general surgery, gynecology, hematology, hepatology, infectious disease, nephrology, neurology, oncology, ophthalmology/optometry, orthopedics, otolaryngology, palliative care, psychiatry/psychology, pulmonology, rheumatology, urology.Medical Services Offered
Chronic GVHD management, fertility counseling, reproductive health, financial counseling, genetic counseling, nutrition/dietetics, occupational therapy, pain management, physical therapy and rehabilitation, sexual health, social services, vaccinations.Telemedicine services are available.Patient Eligibility
Adults- Allogeneic and Autologous transplant recipients
- Adults: 6 months after transplant.
- Adults (over age 18)
- Will provide care to adult patients who underwent transplant as a child
- Does accept patients who were transplanted at another hospital